No ASX ETF holds Mayne Pharma (MYX) as of 15 Oct 2026. Over the last year it fell 60.5%: on $10,000, −$6048. We explain 18 big moves in that time.
About MYX
- SectorHealth Care
- IndustryPharmaceuticals, Biotechnology & Life Sciences
- Size$220.3m
- Held by0 ETFs
- Big moves18 in 1Y
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- −5.7%10 Sep 2026· No Catalyst Found
MYX fell alongside a broad healthcare sector sell-off, with the ASX health index down 2.3% and 36 industry peers down a median 2.3% on the same day.
- +10.2%peak +11.3%3 Aug 2026· Sector Flow
MYX.AX rose sharply alongside a broad rally in the ASX healthcare sector, which gained over 2.3% on the same day, lifting sentiment across health-related stocks.
- +7.5%27 Jun 2026· Sector Flow
The stock price rise appears to be part of a broader positive move in healthcare stocks, with no company-specific news identified.
- +6.7%30 Apr 2026· Earnings Beat
Mayne Pharma reported a strong Q3 update, driving shares up approximately 8%.
- −6.5%9 Apr 2026· Sector Flow
No clear company-specific news on the price move date; likely broad healthcare sector weakness or profit-taking after tariff-related reassurances.
- −8.2%19 Mar 2026· Unknown
No relevant news articles directly explain the 8.19% decline in Mayne Pharma Group on 2026-03-18, leaving the cause unknown.
- −9.4%12 Mar 2026· Unknown
Likely investor reaction to the company's U.S. launch and business model presentation of DistributeRx, which may have raised concerns about costs or execution risks.
- +7.3%11 Mar 2026· Operational
Mayne Pharma hosted a business presentation discussing the U.S. launch and business model of DistributeRx, which was well-received by the market.
- +5.6%10 Mar 2026· Operational
Mayne Pharma discussed the U.S. launch and business model of DistributeRx, likely boosting investor sentiment.
- −7.9%9 Mar 2026· Unknown
No direct news explaining the 7.87% drop was found; the price move appears unexplained by available articles.
- −9.5%12 Feb 2026· Unknown
Insufficient evidence to determine the cause of the price drop.
- −6.6%2 Dec 2025· Unknown
Insufficient evidence to determine the cause of the abnormal price move.
- −18.0%24 Nov 2025· Takeover / M&A
The Australian government objected to the takeover of Mayne Pharma by Cosette, causing the stock to drop sharply.
- +20.9%20 Nov 2025· Takeover / M&A
Mayne Pharma stock surged 20.88% on news of a takeover bid, despite the Australian government later blocking the Cosette acquisition on national interest grounds.
- +5.9%5 Nov 2025· Unknown
Insufficient evidence to determine a specific cause for the price move.
- +7.5%3 Nov 2025· Unknown
No public news was found, so the cause cannot be determined.
- −31.5%31 Oct 2025· Unknown
No news articles were found to explain the price movement.
- +11.3%16 Oct 2025· Takeover / M&A
Court blocked Cosette's attempt to terminate the $438 million takeover deal, clearing a major regulatory hurdle.
Held by 0 ETFs
No ETF we track holds MYX directly.
Other Health Care companies
- SHLSonic Healthcare51 ETFs
- RMDResMed46 ETFs
- CSLCSL Limited45 ETFs
- BDXBcal39 ETFs
- CSXCleanspace37 ETFs
- REGRegis Health34 ETFs
- TLXTelix Pharma34 ETFs
- SIGSigma Healthcare33 ETFs